Liver Transplant; Complications Clinical Trial
Official title:
Effect of N_Acetylcysteine on Liver Functions in Donors in Living Donor Liver Transplantation
Verified date | October 2019 |
Source | Ain Shams University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
our practice for the past 10 years we have noticed a transitional impairment of liver function (elevated liver enzymes, total and direct bilirubin, and elevated serum lactate levels) following donors' liver resection. Several drugs have been investigation on liver regeneration , proven benefit of N-Acetylcysteine (NAC) on rats with steatohpatitis
Status | Completed |
Enrollment | 50 |
Est. completion date | April 1, 2019 |
Est. primary completion date | February 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: - ASA I or II donors - healthy adult Exclusion Criteria: - kidney, liver disease - any contraindications for organ donation |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of medicine | Cairo |
Lead Sponsor | Collaborator |
---|---|
Ain Shams University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Serum lactate | 24 hours postoperative |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05818644 -
Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
|
||
Not yet recruiting |
NCT06041490 -
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation
|
Phase 2 | |
Recruiting |
NCT04443322 -
Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )
|
N/A | |
Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
Completed |
NCT03165916 -
Study to Compare the Incidence of Biliary Complications After Liver Transplantation
|
N/A | |
Withdrawn |
NCT04216303 -
Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
|
||
Recruiting |
NCT04506398 -
Heterogeneity and Evolution of hepatoceLlular Carcinoma in Post-transplant HCC Recurrence
|
||
Not yet recruiting |
NCT05853484 -
Home-based Bimodal Lifestyle Intervention in Patients With Liver Cirrhosis Awaiting Orthotopic Liver Transplantation
|
N/A | |
Not yet recruiting |
NCT05036031 -
Transplantation for EASL-CLIF and APASL ACLF Patients: a Retrospective Cohort Study
|
||
Recruiting |
NCT05065125 -
Clinical Usefulness of Digital Single-operator Cholangioscopy(SpyGlass™) for Post-liver Transplant Anastomotic Stricture
|
||
Recruiting |
NCT06060392 -
Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
|
N/A | |
Enrolling by invitation |
NCT05195944 -
Semaglutide vs Sitagliptin
|
Phase 4 | |
Completed |
NCT05255510 -
Risk of Acute Kidney Injury in Living Liver Donor Surgery
|
||
Not yet recruiting |
NCT06048445 -
Placement of Biliary Drainage Stent to Prevent Biliary Intestinal Anastomosis After Liver Transplantation in Children
|
||
Completed |
NCT05116748 -
COVID19 Vaccine in SOT Adult Recipients
|
||
Completed |
NCT04182256 -
Magnetic Spiderman for Preparation of Liver Donation
|
N/A | |
Recruiting |
NCT04327427 -
Outcome Analysis of Aspirin in Liver Transplantation
|
||
Recruiting |
NCT04477967 -
Design and Implementation of the Pediatric Liver Transplantation Biobank
|
||
Recruiting |
NCT05109156 -
Preoperative Sepsis Timeline, Profile and Its Association With Recipient Outcome Following Live Donor Liver Transplant
|
||
Recruiting |
NCT06124209 -
Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial
|
Phase 4 |